1. Home
  2. BLRX vs REBN Comparison

BLRX vs REBN Comparison

Compare BLRX & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • REBN
  • Stock Information
  • Founded
  • BLRX 2003
  • REBN 2015
  • Country
  • BLRX Israel
  • REBN United States
  • Employees
  • BLRX N/A
  • REBN N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • BLRX Health Care
  • REBN Consumer Discretionary
  • Exchange
  • BLRX Nasdaq
  • REBN Nasdaq
  • Market Cap
  • BLRX 17.3M
  • REBN 18.5M
  • IPO Year
  • BLRX 2011
  • REBN 2022
  • Fundamental
  • Price
  • BLRX $3.59
  • REBN $5.15
  • Analyst Decision
  • BLRX Strong Buy
  • REBN
  • Analyst Count
  • BLRX 2
  • REBN 0
  • Target Price
  • BLRX $220.00
  • REBN N/A
  • AVG Volume (30 Days)
  • BLRX 154.8K
  • REBN 8.1M
  • Earning Date
  • BLRX 03-25-2025
  • REBN 03-27-2025
  • Dividend Yield
  • BLRX N/A
  • REBN N/A
  • EPS Growth
  • BLRX N/A
  • REBN N/A
  • EPS
  • BLRX N/A
  • REBN N/A
  • Revenue
  • BLRX $21,991,000.00
  • REBN $5,502,528.00
  • Revenue This Year
  • BLRX N/A
  • REBN $185.18
  • Revenue Next Year
  • BLRX N/A
  • REBN $64.55
  • P/E Ratio
  • BLRX N/A
  • REBN N/A
  • Revenue Growth
  • BLRX N/A
  • REBN 9.70
  • 52 Week Low
  • BLRX $3.20
  • REBN $0.92
  • 52 Week High
  • BLRX $57.60
  • REBN $8.80
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 36.94
  • REBN 58.19
  • Support Level
  • BLRX $3.26
  • REBN $3.64
  • Resistance Level
  • BLRX $4.17
  • REBN $8.30
  • Average True Range (ATR)
  • BLRX 0.28
  • REBN 1.21
  • MACD
  • BLRX 0.24
  • REBN 0.14
  • Stochastic Oscillator
  • BLRX 36.26
  • REBN 32.48

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: